GSK3β inhibition has emerged as a potential therapeutic approach in amyotrophic lateral sclerosis models by rescuing disease-relevant phenotype, thus enhancing neuronal survival [50]. The gene discussed is GSK3B; the disease is amyotrophic lateral sclerosis.